October is American Pharmacists Month, and we’ve teamed up with the International Pharmaceutical Federation (FIP) to bring you an interview with Dr. Catherine Duggan, CEO, about how pharmacists and the pharmaceutical industry at large can contribute to the fight against antimicrobial resistance.
What Happened to My Baseline? Evidence-Based Care in the COVID-19 Era
“Baselines are used throughout healthcare to evaluate safety, performance, and fiscal execution at the macro and micro level,” writes John Hurst, Pharm D, BCIDP and Senior Director of Antimicrobial Stewardship at bioMérieux.
Acute Kidney Injury is a Frequent Complication of COVID-19
Clinical presentation of kidney involvement from COVID-19 can range from mild proteinuria to progressive AKI, requiring renal replacement therapy (RRT).
Understanding Protective Immunity Can Help Shape Testing & Vaccination Strategies for Fighting COVID-19
To beat the COVID-19 pandemic, a combination of strategies for testing, treatment, vaccination, and community mitigation measures is needed. Research on protective immunity is especially important, both because current understanding is limited and because of its implications for testing strategies and vaccination.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...